BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16643816)

  • 1. Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin.
    Towner D; Gandhi S; El Kady D
    Am J Obstet Gynecol; 2006 Jun; 194(6):1676-81; discussion 1681-2. PubMed ID: 16643816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased maternal serum human chorionic gonadotropin concentrations are an independent risk factor for SGA in dichorionic twin gestations.
    Hershkovitz R; Bar G; Erez O; Smolin A; Sheiner E; Mishori-Dery A; Mazor M
    J Matern Fetal Neonatal Med; 2005 Aug; 18(2):117-22. PubMed ID: 16203597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
    Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
    J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
    Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
    Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol.
    Santolaya-Forgas J; Jessup J; Burd LI; Prins GS; Burton BK
    J Reprod Med; 1996 Feb; 41(2):87-90. PubMed ID: 8656420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated maternal mid-trimester chorionic gonadotropin > or =4 MoM is associated with fetal cerebral blood flow redistribution.
    Hershkovitz R; Erez O; Sheiner E; Landau D; Mankuta D; Mazor M
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):22-7. PubMed ID: 12580835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for adverse perinatal outcome by biomarkers in maternal serum; a comparison of elevated maternal serum alpha-fetoprotein versus human chorionic gonadotropin].
    Tanaka M; Natori M; Ishimoto H; Gohda N; Kiyokawa K; Yamauchi J; Miyazaki T; Kobayashi T; Nozawa S
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1229-33. PubMed ID: 7531210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery.
    Morssink LP; Kornman LH; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1995 Nov; 15(11):1041-6. PubMed ID: 8606883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered newborn gender distribution in patients with low mid-trimester maternal serum human chorionic gonadotropin (MShCG).
    Santolaya-Forgas J; Meyer WJ; Burton BK; Scommegna A
    J Matern Fetal Med; 1997; 6(2):111-4. PubMed ID: 9086428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly.
    Celentano C; Guanciali-Franchi PE; Liberati M; Palka C; Fantasia D; Morizio E; Calabrese G; Stuppia L; Rotmensch S
    Prenat Diagn; 2005 Mar; 25(3):220-4. PubMed ID: 15791663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies.
    Lepage N; Chitayat D; Kingdom J; Huang T
    Am J Obstet Gynecol; 2003 May; 188(5):1354-9. PubMed ID: 12748511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Alabama Preterm Birth Study: diffuse decidual leukocytoclastic necrosis of the decidua basalis, a placental lesion associated with preeclampsia, indicated preterm birth and decreased fetal growth.
    Goldenberg RL; Faye-Petersen O; Andrews WW; Goepfert AR; Cliver SP; Hauth JC
    J Matern Fetal Neonatal Med; 2007 May; 20(5):391-5. PubMed ID: 17674243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The magnitude of elevated maternal serum human chorionic gonadotropin and pregnancy complications.
    Sharony R; Zipper O; Amichay K; Wiser A; Kidron D; Biron-Shental T; Maymon R
    J Obstet Gynaecol; 2017 Jul; 37(5):576-579. PubMed ID: 28604182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstetric outcomes in overweight and obese adolescents.
    Sukalich S; Mingione MJ; Glantz JC
    Am J Obstet Gynecol; 2006 Sep; 195(3):851-5. PubMed ID: 16949425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-trimester serum chorionic gonadotropin concentrations and complications and outcome of pregnancy.
    Walton DL; Norem CT; Schoen EJ; Ray GT; Colby CJ
    N Engl J Med; 1999 Dec; 341(27):2033-8. PubMed ID: 10615074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quad screen as a predictor of adverse pregnancy outcome.
    Dugoff L; Hobbins JC; Malone FD; Vidaver J; Sullivan L; Canick JA; Lambert-Messerlian GM; Porter TF; Luthy DA; Comstock CH; Saade G; Eddleman K; Merkatz IR; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2005 Aug; 106(2):260-7. PubMed ID: 16055573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal asthma and pregnancy outcomes: a retrospective cohort study.
    Liu S; Wen SW; Demissie K; Marcoux S; Kramer MS
    Am J Obstet Gynecol; 2001 Jan; 184(2):90-6. PubMed ID: 11174486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.